TSXV:CLAS.H - Post by User
Comment by
whisky11on Mar 13, 2021 9:43am
242 Views
Post# 32792446
RE:It will take years to go through human trials and they
RE:It will take years to go through human trials and they edrose]DONT HAVE MONEY[
whisky11:YOU WORRY TOO MUCH
.
The estimated cost of the Phase 1 study is CAD $1,040,000
.Following completion of the Phase 1 study, Claritas intends to apply for funding from the U.S. Department of Health and Human Services for the further development of R-107 in COVID-19 infection.
R-107 is Phase 1 Ready Right Now: To date, the development of R-107 has been largely funded by approximately $15 million of federal funds that were provided to Salzman Group under a grant provided by the U.S. Department of Health and Human Services.
The immediate next step is to complete a Phase 1 clinical study to demonstrate that R-107 is safe in humans. This will be followed by Phase 2 and Phase 3 clinicals studies. It is anticipated that the FDA will allow an expedited clinical development pathway for R-107 in this indication.